Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.

Ann Hematol · 2026 · PMC12876546 · PMID 41642496

Europe PMC DOI

hedged sentences

0.0670

closest p · 1.3× alpha

0.1320

boldest claim

The sentences

approaching significancep = 0.067so close (0.05 < p ≤ 0.1)

Interestingly, ORR, CRR and TTNT showed numerical but not statistically significant improvement with higher DDI, with CRR approaching significance ( p = 0.067).

also in 1,108 other papers

did not reach statistical significancep = 0.132not close (p > 0.1)

Among deceased patients, most deaths in the Low DDI group were unrelated to lymphoma (6/9, 66.7%), while in the High DDI group, most were lymphoma-related (5/8, 62.5%), though this difference did not reach statistical significance ( p = 0.132).

also in 58,632 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (&gt; 70 y) with follicular lymphoma: a tertiary academic center experience.

The sentences

Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.